Navigation Links
Epratuzumab Phase IIb Data Presented at ACR Show Pipeline Drug had Positive Effect in Patients Suffering From Moderate to Severe Systemic Lupus Erythematosus
Date:11/9/2010

About ImmunomedicsImmunomedics (NASDAQ: IMMU) is a New Jersey-based biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. Immunomedics has built a pipeline of therapeutic product candidates that utilize several different mechanisms of action. Immunomedics is developing epratuzumab for the therapy of B-cell hematopoietic tumors, such as non-Hodgkin lymphoma and acute lymphoblastic lymphoma.

Forward-looking statements - UCBThis press release contains forward-looking statements based on current plans, estimates and beliefs of management. Such statements are subject to risks and uncertainties that may cause actual results to be materially different from those that may be implied by such forward-looking statements contained in this press release. Important factors that could result in such differences include: changes in general economic, business and competitive conditions, effects of future judicial decisions, changes in regulation, exchange rate fluctuations and hiring and retention of its employees.

Forward looking statements - ImmunomedicsThis release, in addition to historical information, may contain forward-looking statements made pursuant to the Private Securities Litigation Reform Act of 1995. Such statements, including statements regarding clinical trials, out-licensing arrangements (including the timing and amount of contingent payments), forecasts of future operating results, and capital raising activities, involve significant risks and uncertainties and actual results could differ materially from those expressed or implied herein. Factors that could cause such differences include, but are not limited to, risks associated with new product development (including clinical trials outcome and regulat
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
4. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
5. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
8. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
9. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
10. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)...  Actavis plc (NYSE: ACT ), a leading ... , CEO and President of Actavis, will provide an overview ... Global Healthcare Conference 2014 in New York, NY ... The presentation will take place on Tuesday, September 9, ... New York, 109 East 42 nd Street, ...
(Date:8/26/2014)... Aug. 26, 2014 Global design and architecture firm NBBJ announced ... China . Principal Rudy Widjaja will lead planning ... he will draw on his experience with healthcare clients in ... the United States , as well as the firm,s global network ... China healthcare practice comes at a time when the scope ...
(Date:8/26/2014)... 2014 Equashield ( www.equashield.com ), ... for hazardous drugs, announced today it has appointed a ... around the United States . The ... nurses, awareness of issues around occupational exposure to hazardous ... systems for hazardous drug transfer. "As a ...
Breaking Medicine Technology:Actavis to Present at Morgan Stanley Global Healthcare Conference 2014 2Leading Architectural Design Firm NBBJ Launches Healthcare Practice in China 2Leading Architectural Design Firm NBBJ Launches Healthcare Practice in China 3Leading Architectural Design Firm NBBJ Launches Healthcare Practice in China 4Leading Architectural Design Firm NBBJ Launches Healthcare Practice in China 5Equashield Appoints Nurse Advisory Council 2Equashield Appoints Nurse Advisory Council 3Equashield Appoints Nurse Advisory Council 4
... ... International, an independent nonprofit research and development institute, has received two ... the National Institutes of Health (NIH), to develop a stationary X-ray ... is intended to improve three-dimensional imaging technology, which will make it ...
... Ad, " This is Medicare and America at ... WASHINGTON, Dec. 9 The SCOOTER Store today launched a ... and cost savings associated with Medicare,s Power Mobility Benefit, which ... to receive power wheelchairs. , With budget cuts likely in ...
Cached Medicine Technology:SRI International Receives National Institutes of Health Grants to Develop Improved Tomographic Imaging Technology 2SRI International Receives National Institutes of Health Grants to Develop Improved Tomographic Imaging Technology 3The SCOOTER Store Launches New Advertising Highlighting the Value and Cost Savings From Medicare's Power Mobility Benefit 2
(Date:8/27/2014)... A recent University College London (UCL) ... the dental community disagrees on the best way to ... of dental advice suggested that some six different tooth-brushing ... more popular than the rest. , “The easiest ... floss your teeth regularly,” said Dr. Alexandre-Amir Aalam, DDS, ...
(Date:8/27/2014)... "It can be quite difficult to wipe ... an inventor from Lehigh Acres, Fla.," so I designed ... hygienic task." He then created a prototype of his ... user to wipe and clean the behind thoroughly after ... as well as prevents direct contact with waste or ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Neil Haley, the ... Vimillionaire GJ Reynolds to find out about the importance of ... founding member in the company ViSalus and is now a ... Media. He has written a book titled "The Playful and ... the Dale Brown Challenge by working out for over 1000 ...
(Date:8/27/2014)... 2014 AAPC ( http://www.aapc.com ), ... is pleased to announce the Beta release of ... specifically designed for the healthcare industry. , Healthcare ... help address the primary challenges facing the industry—unqualified ... CareerHealth.com . , CareerHealth.com offers ...
(Date:8/27/2014)... August 27, 2014 IntelliSoft Group, LLC, ... management software, will unveil IntelliCred, IntelliApp and ... of Medical Staff Services (NHAMSS) Annual Conference on September ... in Bedford, NH. , Notable improvements available in ... , Contract Linking: A new Contract Connection ...
Breaking Medicine News(10 mins):Health News:Americans Confused About How to Brush Teeth 2Health News:InventHelp Client's Device Helps a User Wipe Thoroughly After Going to the Bathroom (HLW-1300) 2Health News:Vi Millioniare GJ Reynolds Discusses The Importance of Capacity to Grow a Business on the Simply G Radio Show, a Division of the Simply G Media Network 2Health News:Vi Millioniare GJ Reynolds Discusses The Importance of Capacity to Grow a Business on the Simply G Radio Show, a Division of the Simply G Media Network 3Health News:AAPC Responds to Healthcare Workforce Challenges with CareerHealth.com 2Health News:AAPC Responds to Healthcare Workforce Challenges with CareerHealth.com 3Health News:IntelliSoft Group to Unveil Version 14.2 of IntelliCred, IntelliApp and IntelliContract at the New Hampshire Association of Medical Staff Services Annual Conference 2
... , Montreal, May 28, 2009 Sipping wine, beer ... risk of binge drinking, particularly among young men, according to ... Researchers from the Universit de Montral and the University of ... that frequent alcohol consumption can lead to binge drinking among ...
... package testing services firm specializing in medical device package testing, will be ... will help kick off the conference with a powerful presentation by Scotty ... ... -- DDL , the leading package testing services firm specializing in ...
... the Building Owners and Managers Association (BOMA) Southwest ... HeartSine Technologies announced the donation of thirteen HeartSine ... associations of the BOMA Southwest Region. These ... Oklahoma. Because one American dies approximately every two ...
... Early Helps Identify Developmental Delays and Promote GrowthNEW ORLEANS, ... 10:30am - 11:30am , at 1315 Jefferson ... will "Reach Out and Read " with Louisiana,s ... childhood literacy program. In this initiative, pediatricians encourage parents ...
... 28 Aventis Pharmaceutical Inc., a wholly owned subsidiary of ... $95.5 million to settle allegations that it violated the False ... its Medicaid Drug Rebate obligations, the Justice Department announced today. ... The settlement resolves allegations that between 1995 ...
... YORK, May 28 Kyowa Hakko U.S.A., Inc. (Kyowa ... Bio Co., Ltd., (Kyowa), has announced it has completed ... brain health ingredient Cognizin(R) Citicoline. Cognizin(R) is a branded ... cell of the body. Citicoline provides an essential ...
Cached Medicine News:Health News:Daily alcohol intake can lead to binge drinking 2Health News:DDL, Leader in Medical Device Package, Product and Material Testing, will be Presenting at This Year's MD&M Show in New York 2Health News:HeartSafe and HeartSine Announce AED Donation Program to Local BOMA Associations 2Health News:Ochsner Introduces Literacy Program to Promote Healthy Minds 2Health News:Aventis Pharmaceutical to Pay U.S. $95.5 Million to Settle False Claims Act Allegations 2Health News:Kyowa Hakko USA Announces GRAS Self-Affirmation for Novel Brain Health Ingredient Cognizin(R) Citicoline 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: